SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019895
Filing Date
2022-05-12
Accepted
2022-05-12 16:34:15
Documents
63
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q trvi-10q_20220331.htm   iXBRL 10-Q 2115952
2 EX-10.1 trvi-ex101_66.htm EX-10.1 19169
3 EX-31.1 trvi-ex311_10.htm EX-31.1 14009
4 EX-31.2 trvi-ex312_9.htm EX-31.2 13981
5 EX-32.1 trvi-ex321_7.htm EX-32.1 10125
6 EX-32.2 trvi-ex322_8.htm EX-32.2 10085
7 GRAPHIC glrxhh0nxxi2000001.jpg GRAPHIC 40168
  Complete submission text file 0001564590-22-019895.txt   7237654

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA trvi-20220331.xsd EX-101.SCH 49245
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE trvi-20220331_cal.xml EX-101.CAL 38150
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE trvi-20220331_def.xml EX-101.DEF 172247
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE trvi-20220331_lab.xml EX-101.LAB 375801
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trvi-20220331_pre.xml EX-101.PRE 305932
57 EXTRACTED XBRL INSTANCE DOCUMENT trvi-10q_20220331_htm.xml XML 1167778
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38886 | Film No.: 22918435
SIC: 2834 Pharmaceutical Preparations